0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Veterinary Antibiotics Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-5Z7896
Home | Market Reports | Pets & Animals| Animal Products & Services| Veterinarians
China Veterinary Antibiotics Market Report Forecast 2021 2027
BUY CHAPTERS

Global Veterinary Antibiotics Market Research Report 2024

Code: QYRE-Auto-5Z7896
Report
January 2024
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Veterinary Antibiotics Market

Veterinary antibiotics are medications used to treat bacterial infections in animals. They play a crucial role in managing and preventing infectious diseases in livestock, companion animals, and aquaculture.
The global Veterinary Antibiotics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market for veterinary antibiotics is driven by the demand for effective and timely treatment of bacterial infections in animals and the need to prevent the spread of antibiotic-resistant bacteria in veterinary settings. The market's growth is also influenced by regulatory measures promoting responsible antibiotic use in veterinary medicine.
This report aims to provide a comprehensive presentation of the global market for Veterinary Antibiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Antibiotics.

Report Scope

The Veterinary Antibiotics market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Antibiotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Antibiotics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Veterinary Antibiotics Market Report

Report Metric Details
Report Name Veterinary Antibiotics Market
Segment by Type
  • Tetracyclines
  • Penicillins
  • Macrolides
  • Sulphonamides
  • Aminoglycosides
Segment by Application
  • Farm Animals
  • Companion Animals
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Zoetis animal healthcare, Merck, Merial (Animal Health Division Of Sanofi), Elanco, Bayer healthcare, Ceva Animal Health, Inc., Virbac, Boehringer Ingelheim
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Veterinary Antibiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Veterinary Antibiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Veterinary Antibiotics Market report?

Ans: The main players in the Veterinary Antibiotics Market are Zoetis animal healthcare, Merck, Merial (Animal Health Division Of Sanofi), Elanco, Bayer healthcare, Ceva Animal Health, Inc., Virbac, Boehringer Ingelheim

What are the Application segmentation covered in the Veterinary Antibiotics Market report?

Ans: The Applications covered in the Veterinary Antibiotics Market report are Farm Animals, Companion Animals

What are the Type segmentation covered in the Veterinary Antibiotics Market report?

Ans: The Types covered in the Veterinary Antibiotics Market report are Tetracyclines, Penicillins, Macrolides, Sulphonamides, Aminoglycosides

1 Veterinary Antibiotics Market Overview
1.1 Product Overview and Scope of Veterinary Antibiotics
1.2 Veterinary Antibiotics Segment by Type
1.2.1 Global Veterinary Antibiotics Market Value Comparison by Type (2024-2030)
1.2.2 Tetracyclines
1.2.3 Penicillins
1.2.4 Macrolides
1.2.5 Sulphonamides
1.2.6 Aminoglycosides
1.3 Veterinary Antibiotics Segment by Application
1.3.1 Global Veterinary Antibiotics Market Value by Application: (2024-2030)
1.3.2 Farm Animals
1.3.3 Companion Animals
1.4 Global Veterinary Antibiotics Market Size Estimates and Forecasts
1.4.1 Global Veterinary Antibiotics Revenue 2019-2030
1.4.2 Global Veterinary Antibiotics Sales 2019-2030
1.4.3 Global Veterinary Antibiotics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Veterinary Antibiotics Market Competition by Manufacturers
2.1 Global Veterinary Antibiotics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Veterinary Antibiotics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Veterinary Antibiotics Average Price by Manufacturers (2019-2024)
2.4 Global Veterinary Antibiotics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Veterinary Antibiotics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Antibiotics, Product Type & Application
2.7 Veterinary Antibiotics Market Competitive Situation and Trends
2.7.1 Veterinary Antibiotics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Veterinary Antibiotics Players Market Share by Revenue
2.7.3 Global Veterinary Antibiotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Veterinary Antibiotics Retrospective Market Scenario by Region
3.1 Global Veterinary Antibiotics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Veterinary Antibiotics Global Veterinary Antibiotics Sales by Region: 2019-2030
3.2.1 Global Veterinary Antibiotics Sales by Region: 2019-2024
3.2.2 Global Veterinary Antibiotics Sales by Region: 2025-2030
3.3 Global Veterinary Antibiotics Global Veterinary Antibiotics Revenue by Region: 2019-2030
3.3.1 Global Veterinary Antibiotics Revenue by Region: 2019-2024
3.3.2 Global Veterinary Antibiotics Revenue by Region: 2025-2030
3.4 North America Veterinary Antibiotics Market Facts & Figures by Country
3.4.1 North America Veterinary Antibiotics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Veterinary Antibiotics Sales by Country (2019-2030)
3.4.3 North America Veterinary Antibiotics Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Veterinary Antibiotics Market Facts & Figures by Country
3.5.1 Europe Veterinary Antibiotics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Veterinary Antibiotics Sales by Country (2019-2030)
3.5.3 Europe Veterinary Antibiotics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Antibiotics Market Facts & Figures by Country
3.6.1 Asia Pacific Veterinary Antibiotics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Veterinary Antibiotics Sales by Country (2019-2030)
3.6.3 Asia Pacific Veterinary Antibiotics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Veterinary Antibiotics Market Facts & Figures by Country
3.7.1 Latin America Veterinary Antibiotics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Veterinary Antibiotics Sales by Country (2019-2030)
3.7.3 Latin America Veterinary Antibiotics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Antibiotics Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Antibiotics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Veterinary Antibiotics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Veterinary Antibiotics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Veterinary Antibiotics Sales by Type (2019-2030)
4.1.1 Global Veterinary Antibiotics Sales by Type (2019-2024)
4.1.2 Global Veterinary Antibiotics Sales by Type (2025-2030)
4.1.3 Global Veterinary Antibiotics Sales Market Share by Type (2019-2030)
4.2 Global Veterinary Antibiotics Revenue by Type (2019-2030)
4.2.1 Global Veterinary Antibiotics Revenue by Type (2019-2024)
4.2.2 Global Veterinary Antibiotics Revenue by Type (2025-2030)
4.2.3 Global Veterinary Antibiotics Revenue Market Share by Type (2019-2030)
4.3 Global Veterinary Antibiotics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Veterinary Antibiotics Sales by Application (2019-2030)
5.1.1 Global Veterinary Antibiotics Sales by Application (2019-2024)
5.1.2 Global Veterinary Antibiotics Sales by Application (2025-2030)
5.1.3 Global Veterinary Antibiotics Sales Market Share by Application (2019-2030)
5.2 Global Veterinary Antibiotics Revenue by Application (2019-2030)
5.2.1 Global Veterinary Antibiotics Revenue by Application (2019-2024)
5.2.2 Global Veterinary Antibiotics Revenue by Application (2025-2030)
5.2.3 Global Veterinary Antibiotics Revenue Market Share by Application (2019-2030)
5.3 Global Veterinary Antibiotics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Zoetis animal healthcare
6.1.1 Zoetis animal healthcare Corporation Information
6.1.2 Zoetis animal healthcare Description and Business Overview
6.1.3 Zoetis animal healthcare Veterinary Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Zoetis animal healthcare Veterinary Antibiotics Product Portfolio
6.1.5 Zoetis animal healthcare Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Veterinary Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Veterinary Antibiotics Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Merial (Animal Health Division Of Sanofi)
6.3.1 Merial (Animal Health Division Of Sanofi) Corporation Information
6.3.2 Merial (Animal Health Division Of Sanofi) Description and Business Overview
6.3.3 Merial (Animal Health Division Of Sanofi) Veterinary Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merial (Animal Health Division Of Sanofi) Veterinary Antibiotics Product Portfolio
6.3.5 Merial (Animal Health Division Of Sanofi) Recent Developments/Updates
6.4 Elanco
6.4.1 Elanco Corporation Information
6.4.2 Elanco Description and Business Overview
6.4.3 Elanco Veterinary Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Elanco Veterinary Antibiotics Product Portfolio
6.4.5 Elanco Recent Developments/Updates
6.5 Bayer healthcare
6.5.1 Bayer healthcare Corporation Information
6.5.2 Bayer healthcare Description and Business Overview
6.5.3 Bayer healthcare Veterinary Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bayer healthcare Veterinary Antibiotics Product Portfolio
6.5.5 Bayer healthcare Recent Developments/Updates
6.6 Ceva Animal Health, Inc.
6.6.1 Ceva Animal Health, Inc. Corporation Information
6.6.2 Ceva Animal Health, Inc. Description and Business Overview
6.6.3 Ceva Animal Health, Inc. Veterinary Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ceva Animal Health, Inc. Veterinary Antibiotics Product Portfolio
6.6.5 Ceva Animal Health, Inc. Recent Developments/Updates
6.7 Virbac
6.6.1 Virbac Corporation Information
6.6.2 Virbac Description and Business Overview
6.6.3 Virbac Veterinary Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Virbac Veterinary Antibiotics Product Portfolio
6.7.5 Virbac Recent Developments/Updates
6.8 Boehringer Ingelheim
6.8.1 Boehringer Ingelheim Corporation Information
6.8.2 Boehringer Ingelheim Description and Business Overview
6.8.3 Boehringer Ingelheim Veterinary Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Boehringer Ingelheim Veterinary Antibiotics Product Portfolio
6.8.5 Boehringer Ingelheim Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Antibiotics Industry Chain Analysis
7.2 Veterinary Antibiotics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Antibiotics Production Mode & Process
7.4 Veterinary Antibiotics Sales and Marketing
7.4.1 Veterinary Antibiotics Sales Channels
7.4.2 Veterinary Antibiotics Distributors
7.5 Veterinary Antibiotics Customers
8 Veterinary Antibiotics Market Dynamics
8.1 Veterinary Antibiotics Industry Trends
8.2 Veterinary Antibiotics Market Drivers
8.3 Veterinary Antibiotics Market Challenges
8.4 Veterinary Antibiotics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Veterinary Antibiotics Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Veterinary Antibiotics Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Veterinary Antibiotics Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Veterinary Antibiotics Sales (K MT) of Key Manufacturers (2019-2024)
    Table 5. Global Veterinary Antibiotics Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Veterinary Antibiotics Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Veterinary Antibiotics Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Veterinary Antibiotics Average Price (US$/MT) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Veterinary Antibiotics, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Veterinary Antibiotics, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Veterinary Antibiotics, Product Type & Application
    Table 12. Global Key Manufacturers of Veterinary Antibiotics, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Veterinary Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Antibiotics as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Veterinary Antibiotics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Veterinary Antibiotics Sales by Region (2019-2024) & (K MT)
    Table 18. Global Veterinary Antibiotics Sales Market Share by Region (2019-2024)
    Table 19. Global Veterinary Antibiotics Sales by Region (2025-2030) & (K MT)
    Table 20. Global Veterinary Antibiotics Sales Market Share by Region (2025-2030)
    Table 21. Global Veterinary Antibiotics Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Veterinary Antibiotics Revenue Market Share by Region (2019-2024)
    Table 23. Global Veterinary Antibiotics Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Veterinary Antibiotics Revenue Market Share by Region (2025-2030)
    Table 25. North America Veterinary Antibiotics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Veterinary Antibiotics Sales by Country (2019-2024) & (K MT)
    Table 27. North America Veterinary Antibiotics Sales by Country (2025-2030) & (K MT)
    Table 28. North America Veterinary Antibiotics Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Veterinary Antibiotics Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Veterinary Antibiotics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Veterinary Antibiotics Sales by Country (2019-2024) & (K MT)
    Table 32. Europe Veterinary Antibiotics Sales by Country (2025-2030) & (K MT)
    Table 33. Europe Veterinary Antibiotics Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Veterinary Antibiotics Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Veterinary Antibiotics Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Veterinary Antibiotics Sales by Region (2019-2024) & (K MT)
    Table 37. Asia Pacific Veterinary Antibiotics Sales by Region (2025-2030) & (K MT)
    Table 38. Asia Pacific Veterinary Antibiotics Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Veterinary Antibiotics Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Veterinary Antibiotics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Veterinary Antibiotics Sales by Country (2019-2024) & (K MT)
    Table 42. Latin America Veterinary Antibiotics Sales by Country (2025-2030) & (K MT)
    Table 43. Latin America Veterinary Antibiotics Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Veterinary Antibiotics Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Veterinary Antibiotics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Veterinary Antibiotics Sales by Country (2019-2024) & (K MT)
    Table 47. Middle East & Africa Veterinary Antibiotics Sales by Country (2025-2030) & (K MT)
    Table 48. Middle East & Africa Veterinary Antibiotics Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Veterinary Antibiotics Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Veterinary Antibiotics Sales (K MT) by Type (2019-2024)
    Table 51. Global Veterinary Antibiotics Sales (K MT) by Type (2025-2030)
    Table 52. Global Veterinary Antibiotics Sales Market Share by Type (2019-2024)
    Table 53. Global Veterinary Antibiotics Sales Market Share by Type (2025-2030)
    Table 54. Global Veterinary Antibiotics Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Veterinary Antibiotics Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Veterinary Antibiotics Revenue Market Share by Type (2019-2024)
    Table 57. Global Veterinary Antibiotics Revenue Market Share by Type (2025-2030)
    Table 58. Global Veterinary Antibiotics Price (US$/MT) by Type (2019-2024)
    Table 59. Global Veterinary Antibiotics Price (US$/MT) by Type (2025-2030)
    Table 60. Global Veterinary Antibiotics Sales (K MT) by Application (2019-2024)
    Table 61. Global Veterinary Antibiotics Sales (K MT) by Application (2025-2030)
    Table 62. Global Veterinary Antibiotics Sales Market Share by Application (2019-2024)
    Table 63. Global Veterinary Antibiotics Sales Market Share by Application (2025-2030)
    Table 64. Global Veterinary Antibiotics Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Veterinary Antibiotics Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Veterinary Antibiotics Revenue Market Share by Application (2019-2024)
    Table 67. Global Veterinary Antibiotics Revenue Market Share by Application (2025-2030)
    Table 68. Global Veterinary Antibiotics Price (US$/MT) by Application (2019-2024)
    Table 69. Global Veterinary Antibiotics Price (US$/MT) by Application (2025-2030)
    Table 70. Zoetis animal healthcare Corporation Information
    Table 71. Zoetis animal healthcare Description and Business Overview
    Table 72. Zoetis animal healthcare Veterinary Antibiotics Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 73. Zoetis animal healthcare Veterinary Antibiotics Product
    Table 74. Zoetis animal healthcare Recent Developments/Updates
    Table 75. Merck Corporation Information
    Table 76. Merck Description and Business Overview
    Table 77. Merck Veterinary Antibiotics Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 78. Merck Veterinary Antibiotics Product
    Table 79. Merck Recent Developments/Updates
    Table 80. Merial (Animal Health Division Of Sanofi) Corporation Information
    Table 81. Merial (Animal Health Division Of Sanofi) Description and Business Overview
    Table 82. Merial (Animal Health Division Of Sanofi) Veterinary Antibiotics Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 83. Merial (Animal Health Division Of Sanofi) Veterinary Antibiotics Product
    Table 84. Merial (Animal Health Division Of Sanofi) Recent Developments/Updates
    Table 85. Elanco Corporation Information
    Table 86. Elanco Description and Business Overview
    Table 87. Elanco Veterinary Antibiotics Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 88. Elanco Veterinary Antibiotics Product
    Table 89. Elanco Recent Developments/Updates
    Table 90. Bayer healthcare Corporation Information
    Table 91. Bayer healthcare Description and Business Overview
    Table 92. Bayer healthcare Veterinary Antibiotics Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 93. Bayer healthcare Veterinary Antibiotics Product
    Table 94. Bayer healthcare Recent Developments/Updates
    Table 95. Ceva Animal Health, Inc. Corporation Information
    Table 96. Ceva Animal Health, Inc. Description and Business Overview
    Table 97. Ceva Animal Health, Inc. Veterinary Antibiotics Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 98. Ceva Animal Health, Inc. Veterinary Antibiotics Product
    Table 99. Ceva Animal Health, Inc. Recent Developments/Updates
    Table 100. Virbac Corporation Information
    Table 101. Virbac Description and Business Overview
    Table 102. Virbac Veterinary Antibiotics Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 103. Virbac Veterinary Antibiotics Product
    Table 104. Virbac Recent Developments/Updates
    Table 105. Boehringer Ingelheim Corporation Information
    Table 106. Boehringer Ingelheim Description and Business Overview
    Table 107. Boehringer Ingelheim Veterinary Antibiotics Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 108. Boehringer Ingelheim Veterinary Antibiotics Product
    Table 109. Boehringer Ingelheim Recent Developments/Updates
    Table 110. Key Raw Materials Lists
    Table 111. Raw Materials Key Suppliers Lists
    Table 112. Veterinary Antibiotics Distributors List
    Table 113. Veterinary Antibiotics Customers List
    Table 114. Veterinary Antibiotics Market Trends
    Table 115. Veterinary Antibiotics Market Drivers
    Table 116. Veterinary Antibiotics Market Challenges
    Table 117. Veterinary Antibiotics Market Restraints
    Table 118. Research Programs/Design for This Report
    Table 119. Key Data Information from Secondary Sources
    Table 120. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Veterinary Antibiotics
    Figure 2. Global Veterinary Antibiotics Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Veterinary Antibiotics Market Share by Type in 2023 & 2030
    Figure 4. Tetracyclines Product Picture
    Figure 5. Penicillins Product Picture
    Figure 6. Macrolides Product Picture
    Figure 7. Sulphonamides Product Picture
    Figure 8. Aminoglycosides Product Picture
    Figure 9. Global Veterinary Antibiotics Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 10. Global Veterinary Antibiotics Market Share by Application in 2023 & 2030
    Figure 11. Farm Animals
    Figure 12. Companion Animals
    Figure 13. Global Veterinary Antibiotics Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Veterinary Antibiotics Market Size (2019-2030) & (US$ Million)
    Figure 15. Global Veterinary Antibiotics Sales (2019-2030) & (K MT)
    Figure 16. Global Veterinary Antibiotics Average Price (US$/MT) & (2019-2030)
    Figure 17. Veterinary Antibiotics Report Years Considered
    Figure 18. Veterinary Antibiotics Sales Share by Manufacturers in 2023
    Figure 19. Global Veterinary Antibiotics Revenue Share by Manufacturers in 2023
    Figure 20. The Global 5 and 10 Largest Veterinary Antibiotics Players: Market Share by Revenue in 2023
    Figure 21. Veterinary Antibiotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 22. Global Veterinary Antibiotics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 23. North America Veterinary Antibiotics Sales Market Share by Country (2019-2030)
    Figure 24. North America Veterinary Antibiotics Revenue Market Share by Country (2019-2030)
    Figure 25. United States Veterinary Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Canada Veterinary Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Europe Veterinary Antibiotics Sales Market Share by Country (2019-2030)
    Figure 28. Europe Veterinary Antibiotics Revenue Market Share by Country (2019-2030)
    Figure 29. Germany Veterinary Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. France Veterinary Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. U.K. Veterinary Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Italy Veterinary Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Russia Veterinary Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Veterinary Antibiotics Sales Market Share by Region (2019-2030)
    Figure 35. Asia Pacific Veterinary Antibiotics Revenue Market Share by Region (2019-2030)
    Figure 36. China Veterinary Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Japan Veterinary Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. South Korea Veterinary Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. India Veterinary Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Australia Veterinary Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. China Taiwan Veterinary Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Indonesia Veterinary Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Thailand Veterinary Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Malaysia Veterinary Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Latin America Veterinary Antibiotics Sales Market Share by Country (2019-2030)
    Figure 46. Latin America Veterinary Antibiotics Revenue Market Share by Country (2019-2030)
    Figure 47. Mexico Veterinary Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Brazil Veterinary Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Argentina Veterinary Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa Veterinary Antibiotics Sales Market Share by Country (2019-2030)
    Figure 51. Middle East & Africa Veterinary Antibiotics Revenue Market Share by Country (2019-2030)
    Figure 52. Turkey Veterinary Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Veterinary Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. UAE Veterinary Antibiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Global Sales Market Share of Veterinary Antibiotics by Type (2019-2030)
    Figure 56. Global Revenue Market Share of Veterinary Antibiotics by Type (2019-2030)
    Figure 57. Global Veterinary Antibiotics Price (US$/MT) by Type (2019-2030)
    Figure 58. Global Sales Market Share of Veterinary Antibiotics by Application (2019-2030)
    Figure 59. Global Revenue Market Share of Veterinary Antibiotics by Application (2019-2030)
    Figure 60. Global Veterinary Antibiotics Price (US$/MT) by Application (2019-2030)
    Figure 61. Veterinary Antibiotics Value Chain
    Figure 62. Veterinary Antibiotics Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS